spacer
spacer

PDBsum entry 2p2c

Go to PDB code: 
protein Protein-protein interface(s) links
Hydrolase PDB id
2p2c

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
(+ 0 more) 162 a.a. *
(+ 0 more) 96 a.a. *
(+ 0 more) 158 a.a. *
Waters ×29
* Residue conservation analysis
PDB id:
2p2c
Name: Hydrolase
Title: Inhibition of caspase-2 by a designed ankyrin repeat protein (darpin)
Structure: Caspase-2. Chain: a, c, e, g, i, k. Fragment: residues 167-333. Caspase-2. Chain: b, d, f, h, j, l. Fragment: residues 348-452. Engineered: yes. Caspase-2. Chain: p, q, r, s, t, u.
Source: Homo sapiens. Human. Organism_taxid: 9606. Strain: bl21(de3). Gene: casp2. Gene: casp2
Resolution:
3.24Å     R-factor:   0.262     R-free:   0.305
Authors: H.Roschitzki Voser,C.Briand,G.Capitani,M.G.Gruetter
Key ref:
A.Schweizer et al. (2007). Inhibition of Caspase-2 by a Designed Ankyrin Repeat Protein: Specificity, Structure, and Inhibition Mechanism. Structure, 15, 625-636. PubMed id: 17502107 DOI: 10.1016/j.str.2007.03.014
Date:
07-Mar-07     Release date:   22-May-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P42575  (CASP2_HUMAN) -  Caspase-2 from Homo sapiens
Seq:
Struc:
452 a.a.
162 a.a.*
Protein chains
Pfam   ArchSchema ?
P42575  (CASP2_HUMAN) -  Caspase-2 from Homo sapiens
Seq:
Struc:
452 a.a.
96 a.a.
Protein chains
No UniProt id for this chain
Struc: 158 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chains A, B, C, D, E, F, G, H, I, J, K, L: E.C.3.4.22.55  - caspase-2.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1016/j.str.2007.03.014 Structure 15:625-636 (2007)
PubMed id: 17502107  
 
 
Inhibition of Caspase-2 by a Designed Ankyrin Repeat Protein: Specificity, Structure, and Inhibition Mechanism.
A.Schweizer, H.Roschitzki-Voser, P.Amstutz, C.Briand, M.Gulotti-Georgieva, E.Prenosil, H.K.Binz, G.Capitani, A.Baici, A.Pl?ckthun, M.G.Gr?tter.
 
  ABSTRACT  
 
Specific and potent caspase inhibitors are indispensable for the dissection of the intricate pathways leading to apoptosis. We selected a designed ankyrin repeat protein (DARPin) from a combinatorial library that inhibits caspase-2 in vitro with a subnanomolar inhibition constant and, in contrast to the peptidic caspase inhibitors, with very high specificity for this particular caspase. The crystal structure of this inhibitor (AR_F8) in complex with caspase-2 reveals the molecular basis for the specificity and, together with kinetic analyses, the allosteric mechanism of inhibition. The structure also shows a conformation of the active site that can be exploited for the design of inhibitory compounds. AR_F8 is a specific inhibitor of an initiator caspase and has the potential to help identify the function of caspase-2 in the complex biological apoptotic signaling network.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. Stereo Representation of the Structure of the Caspase-2/AR_F8 Complex
Caspase-2 is shown in dark blue (α subunit) and light blue (β subunit), and AR_F8 is shown in salmon. AR_F8 is bound to the back side of the active-site-forming loop 381 (see Figure 5C) of each caspase-2 monomer. Termini and loops affected by binding of AR_F8 are shown in red. The active-site cysteine (Cys285) and the intersubunit disulfide bond are shown in yellow.
Figure 3.
Figure 3. Molecular Interactions between AR_F8 and Caspase-2
Stereo representation of the caspase-2/AR_F8 interface rotated vert, similar 90° from the standard orientation, viewed from the back plane of the caspase, displaying hydrogen bonds (green, dotted lines) and hydrophobic interactions. Interacting residues of AR_F8 are shown in red; those of caspase-2 are shown in blue.
 
  The above figures are reprinted by permission from Cell Press: Structure (2007, 15, 625-636) copyright 2007.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21296164 N.Monroe, G.Sennhauser, M.A.Seeger, C.Briand, and M.G.Grütter (2011).
Designed ankyrin repeat protein binders for the crystallization of AcrB: plasticity of the dominant interface.
  J Struct Biol, 174, 269-281.
PDB codes: 3noc 3nog
21053238 C.J.Farady, and C.S.Craik (2010).
Mechanisms of macromolecular protease inhibitors.
  Chembiochem, 11, 2341-2346.  
20070239 D.X.Hou, and T.Kumamoto (2010).
Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling.
  Antioxid Redox Signal, 13, 691-719.  
21134639 J.M.Lipchock, and J.P.Loria (2010).
Nanometer propagation of millisecond motions in V-type allostery.
  Structure, 18, 1596-1607.  
20811381 M.Drag, and G.S.Salvesen (2010).
Emerging principles in protease-based drug discovery.
  Nat Rev Drug Discov, 9, 690-701.  
19591507 C.F.Cervantes, P.R.Markwick, S.C.Sue, J.A.McCammon, H.J.Dyson, and E.A.Komives (2009).
Functional dynamics of the folded ankyrin repeats of IkappaB alpha revealed by nuclear magnetic resonance.
  Biochemistry, 48, 8023-8031.  
19740746 D.Veesler, B.Dreier, S.Blangy, J.Lichière, D.Tremblay, S.Moineau, S.Spinelli, M.Tegoni, A.Plückthun, V.Campanacci, and C.Cambillau (2009).
Crystal structure and function of a DARPin neutralizing inhibitor of lactococcal phage TP901-1: comparison of DARPin and camelid VHH binding mode.
  J Biol Chem, 284, 30718-30726.
PDB code: 3hg0
19208804 J.Gao, S.S.Sidhu, and J.A.Wells (2009).
Two-state selection of conformation-specific antibodies.
  Proc Natl Acad Sci U S A, 106, 3071-3076.  
19501012 M.Gebauer, and A.Skerra (2009).
Engineered protein scaffolds as next-generation antibody therapeutics.
  Curr Opin Chem Biol, 13, 245-255.  
19389717 P.Milovnik, D.Ferrari, C.A.Sarkar, and A.Plückthun (2009).
Selection and characterization of DARPins specific for the neurotensin receptor 1.
  Protein Eng Des Sel, 22, 357-366.  
  19298050 S.Koide, and S.S.Sidhu (2009).
The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins.
  ACS Chem Biol, 4, 325-334.  
19477632 S.Koide (2009).
Engineering of recombinant crystallization chaperones.
  Curr Opin Struct Biol, 19, 449-457.  
19479377 T.Kitevska, D.M.Spencer, and C.J.Hawkins (2009).
Caspase-2: controversial killer or checkpoint controller?
  Apoptosis, 14, 829-848.  
18654624 A.Schweizer, P.Rusert, L.Berlinger, C.R.Ruprecht, A.Mann, S.Corthésy, S.G.Turville, M.Aravantinou, M.Fischer, M.Robbiani, P.Amstutz, and A.Trkola (2008).
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristics.
  PLoS Pathog, 4, e1000109.  
18243686 D.Barrick, D.U.Ferreiro, and E.A.Komives (2008).
Folding landscapes of ankyrin repeat proteins: experiments meet theory.
  Curr Opin Struct Biol, 18, 27-34.  
18560151 D.Frey, T.Huber, A.Plückthun, and M.G.Grütter (2008).
Structure of the recombinant antibody Fab fragment f3p4.
  Acta Crystallogr D Biol Crystallogr, 64, 636-643.
PDB code: 2v7n
18187656 D.Grueninger, N.Treiber, M.O.Ziegler, J.W.Koetter, M.S.Schulze, and G.E.Schulz (2008).
Designed protein-protein association.
  Science, 319, 206-209.
PDB codes: 2uyu 2uyv 2v7g 2v9e 2v9f 2v9g 2v9i 2v9l 2v9m 2v9n 2v9o 2v9u
17963718 E.Kloss, N.Courtemanche, and D.Barrick (2008).
Repeat-protein folding: new insights into origins of cooperativity, stability, and topology.
  Arch Biochem Biophys, 469, 83-99.  
18382651 K.Anestål, S.Prast-Nielsen, N.Cenas, and E.S.Arnér (2008).
Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells.
  PLoS ONE, 3, e1846.  
18621567 M.T.Stumpp, H.K.Binz, and P.Amstutz (2008).
DARPins: a new generation of protein therapeutics.
  Drug Discov Today, 13, 695-701.  
19021141 P.Hauske, C.Ottmann, M.Meltzer, M.Ehrmann, and M.Kaiser (2008).
Allosteric regulation of proteases.
  Chembiochem, 9, 2920-2928.  
18391401 T.M.Bandeiras, R.C.Hillig, P.M.Matias, U.Eberspaecher, J.Fanghänel, M.Thomaz, S.Miranda, K.Crusius, V.Pütter, P.Amstutz, M.Gulotti-Georgieva, H.K.Binz, C.Holz, A.A.Schmitz, C.Lang, P.Donner, U.Egner, M.A.Carrondo, and B.Müller-Tiemann (2008).
Structure of wild-type Plk-1 kinase domain in complex with a selective DARPin.
  Acta Crystallogr D Biol Crystallogr, 64, 339-353.
PDB code: 2v5q
18445622 V.Tereshko, S.Uysal, A.Koide, K.Margalef, S.Koide, and A.A.Kossiakoff (2008).
Toward chaperone-assisted crystallography: protein engineering enhancement of crystal packing and X-ray phasing capabilities of a camelid single-domain antibody (VHH) scaffold.
  Protein Sci, 17, 1175-1187.
PDB codes: 2p42 2p43 2p44 2p45 2p46 2p47 2p48
17502096 G.S.Salvesen, and S.J.Riedl (2007).
Caspase inhibition, specifically.
  Structure, 15, 513-514.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer